Huvepharma® Acquires T-HEXX Animal Health & Qalian, an InVivo & Meriel company

Huvepharma®, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. and the Animal Health Division of Neovia, from InVivo Group, a move that will expand the EU focus on livestock animal health products, and includes Qalian France (Segré), Meriel France (hygiene line, St Etienne, France), Qalian Portugal (Lisbon) and Qalian Italy (Carpi) and the branded veterinary pharmaceuticals (drugs & premix), animal dietetics and hygiene product lines.
The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.  T-HEXX Animal Health manufacturers and sells a broad range of products utilizing patented hydrophilic polymer technologies designed for mastitis management in dairy cattle, hoof care, and unique germicidal topical products for horses. They serve customers in the U.S. and internationally.
On the T-HEXX acquisition, Mr. Glen Wilkinson, President of Huvepharma U.S. remarked “The purchase of T-HEXX Animal Health supports Huvepharma’s vision for growth and development.  T-HEXX has created great products for the dairy and equine markets and we are thrilled to add these unique product lines to our portfolio.”
“Huvepharma will immediately assume marketing and sales of T-HEXX brands to our current customers while utilizing the sales and marketing strengths of AgriLabs. This timely purchase appropriately follows the recent announcement of a new dairy cattle vaccine – KLEBVax SRP”, added Mr. Wilkinson.
On the Qalian acquisition, Dr. Christian Vervaet (DVM), EU Sales Director Huvepharma said “We’re very excited about this addition to our EU animal health business”. “This acquisition furthers Huvepharma’s strategy in creating a balanced portfolio of animal health products and enhancing our presence in Europe and our international markets. We will be in a better position to serve our customers with an extended high quality product range, the Qalian team and the complementary production facilities. Huvepharma and Qalian are strong, complementary businesses focused on providing real solutions for animal health,” Dr. Vervaet added.
Mr. Alex Klein (DVM), General Manager Qalian France said “We’re pleased to join Huvepharma’s internationally recognized animal health company.  This move will provide us with resources to quickly bring new solutions to veterinarians and producers. It will also allow us to accelerate the international development of our ranges of products”.
Huvepharma SEA (Pune) Pvt. Ltd.’s Managing Director, Mr. O.P. Singh expressed his excitement and appreciation of the acquisitions.  In his words “Huvepharma Group’s dedication to the animal health industry finds its expression time and again through their commitment to expansion, upgrade and increased investments in acquiring specialized products and companies.  This dedication is the cornerstone of quality deliverables and makes the Group reliable and lasting.  Huvepharma SEA is pleased to be a part of such an organization and we, as always, look forward to our contribution in strengthening the bond with our esteemed customers & stakeholders through the wide range of products and services with the highest degree of technological innovations and scientific platforms.”